Studies

The Treat Asia HIV Observational Database (TAHOD)

December 31, 2018

Project no.: HIV-NAT 048

This study collects observational data on HIV-infected patients from a number of sites in several Asian countries. The information gathered will help develop more effective research and treatment programs for people living with HIV/AIDS in the region.

Publications:

  1. J Acquir Immune Defic Syndr. 2006;43(4):501-503.
  2. Antiviral Therapy 2007; 12(Suppl. 2):L45.
  3. Clin Infect Dis. 2007; 44(1): 147-149.
  4. HIV Medicine. 2007; 1(8): 8–16.
  5. Int J STD AIDS. 2007;18(7):446-52.
  6. HIV Med. 2007, 8(7): 465-471.
  7. AIDS Res Treat. 2007, 4:18.
  8. J Gastroenterol Hepatol 2007;22(9):1510-1518.
  9. BMC Infect Dis. 2009;9:46.
  10. Clin Infect Dis. 2009;48(7):940-50.
  11. J Antivir Antiretrovir. 2009;1(1):28-35.
  12. HIV Medicine 2010;(1):31-39.
  13. HIV Med. 2010;11(8):519-29.
  14. AIDS Clin Res. 2010;1(1):1-4.
  15. BMC Infect Dis. 2010;10:361.
  16. J Int AIDS Soc. 2010;13:51.
  17. Endocr J. Endocr J. 2011;58(6):475-84.
  18. AIDS Res Treat. 2012;2012:375217.
  19. J Int AIDS Soc. 2012;15(1):1
  20. PLoS One. 2013;8(6):e64902.
  21. Acquir Immune Defic Syndr 2013;63(4):472-9.
  22. J Acquir Immune Defic Syndr. 2013;62(3):293-300. 
  23. J Int Assoc Physicians AIDS Care (Chic). 2013;12(4):270-7.
  24. J Acquir Immune Defic Syndr. 2014;66(5):e108-11. 
  25. J Acquir Immune Defic Syndr. 2014;65(4):463-72.
  26. J Int AIDS Soc. 2014;17:18804. 
  27. HIV Med. 2014;15(2):77-85.
  28. PLOS One 2014;9(9):e106525.
  29. Efficacy of second-line antiretroviral therapy among people living with HIV/AIDS in Asia: Results from the TREAT Asia HIV Observational Database. J Acquir Immune Defic Syndr. 2014 In Press
  30. A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV Observational Database. J Acquir Immune Defic Syndr. 2014 In Press. PMID: 25197829

Presentations:

  1. AIDS defining illness diagnosed within 90 days after starting HAART among TAHOD patients. Presented at the 3th IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, 24-27 July 2005
  2. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine among TAHOD patients. Presented at the 17th ASHM Conference, Hobart, Australia, 24 – 27 August 2005
  3. Difference between Asian and Caucasian HIV-infected patients in absolute CD4 count and CD4 percentage. Presented at the 10th International Workshop on HIV Observational Databases, Madrid, Spain, March 23-26, 2006 and XVI International AIDS Conference. Toronto, Canada 13-18 August 2006
  4. Risk of active tuberculosis (TB) and prognostic significance of tuberculosis among TAHOD patients. Presented at the 10th International Workshop on HIV Observational Databases, Madrid, Spain, March 23-26, 2006 and XVI International AIDSConference. Toronto, Canada 13-18 August 2006
  5. Parametric models of immunological failure in HIV-infected Thais receiving antiretrovirals at HIV-NAT and validation using the TAHOD. Presented at the 18th Annual Conference of the Australasian Society for HIV Medicine. Melbourne, Australia, 11 to 14 October 2006
  6. Experience Using AZT and d4T in TAHOD Patients: Treatment Duration and AZT Related Anaemia. Presented at the 14th CROI, Los Angeles, USA, Feb 25-28, 2007
  7. Data Collection for Antiretroviral Treatment Related Adverse Events (AEs) in The TREAT Asia Observational Database. Presented at the 11th International workshop on HIV Observational
  8. Databases, Monte Carlo, 22-25 March 2007
  9. Antiretroviral Treatment Related Adverse Events (AEs) in The TREAT Asia HIV Observational Database. Presented at the 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Sydney, 19–21st July 2007
  10. Measures of country-specific resourcing predict virologic suppression, immunologic response and disease progression in the TREAT. Presented by the 12th International Workshop on HIV Observational Databases, Malaga, Spain, 28 March 2008 and 20th Annual Australasian Society for HIV Medicine (ASHM) Conference, Perth, 17-20 September 2008
  11. Deferred modification of antiretroviral regimen following treatment failure in Asia: Results from The TREAT Asia HIV Observational Database (TAHOD). [Poster#: TUPE0116]Presented at the 17th International AIDS Conference, Mexico City, Mexico, 3-8 August 2008
  12. HIV Disease Progression In HIV-1 Patients Initiating Combination Antiretroviral Therapy With Advanced Disease In The Asia-Pacific Region: Results From The TREAT Asia HIV Observational Database (TAHOD). Presented at the 20th Annual Australasian Society for HIV Medicine (ASHM) Conference, Perth, Australia, 17-20 September 2008
  13. Short-Term Clinical Disease Progression in HIV-1-Positive Patients Taking Combination. Presented at the 20th Annual Australasian Society for HIV Medicine (ASHM) Conference, Perth, Australia, 17-20 September 2008
  14. Patient characteristics and treatment outcomes associated with protease inhibitor (PI) use in the Asia-Pacific region [Abstract #: P_72] Presented at the 9th International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 9–13 November 2008
  15. Short-term risk of anemia following initiation of antiretroviral treatment in HIV-infected patients in countries from sub-Saharan Africa and Asia. Presented at the 14th International Workshop on HIV Observational Databases, Lisbon, Portugal, 25th – 27th March 2009
  16. Short-term risk of anemia following initiation of antiretroviral treatment in HIV-infected patients in countries from sub-Saharan Africa and Asia. [Abstract #: 200721711] Presented at the 5th International AIDS Society Conference, Cape Town, Africa, 19-22  July 2009 
  17. Prevalence and Risk Factors of Lipodystrophy among HIVinfected Persons Receiving HAART in the Asia-Pacific Region: Results from the TREAT Asia HIV Observational Database. [Abstract #: H1576] presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, California, USA,  16-18 September 2009
  18. Non-virological criteria to predict virological failure in TAHOD and IeDEA SA. Presented at the IeDEA Satellite Meeting, San Francisco, USA, 20 February 2010
  19. Trend of CD4 cell count in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment. Presented at the The 14th International Workshop on HIV Observational Databases, Sitges, Spain, 5-27 March 2010
  20. Impact of sex on long-term treatment outcomes of highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database [Abstract #: 200736571] presented at the International AIDS Society Conference  2010, Vienna, Austria, 18-23 July 2010
  21. Impact of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Co-infections on Immunological Responses to HAART in the TREAT Asia HIV Observational Database (TAHOD) [Abstract #: 200739465] presented at the International AIDS Society Conference  2010, Vienna, Austria, 18-23 July 2010
  22. High Prevalence of Anal Squamous Intraepithelial Lesions in HIV-positive and HIV-negative Men who have sex with Men in Thailand presented at the International AIDS Society Conference  (IAS) 2010, Vienna, Austria, 18-23 July 2010
  23. Lack of prophylaxis against Pneumocystis pneumonia and mortality: Results from the TREAT Asia HIV Observational Database (TAHOD) [Abstract #: H213] presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Boston, USA, 12-15 September 2010
  24. Time Trends of CD4 Cell Count Levels at the Initiation of Antiretroviral Therapy among Asian HIV-infected Patients. 20th CROI,  Atlanta, USA, 3-6 March 2013
  25. Second-line antiretroviral therapy in HIV-infected patients in Asia: results from the TREAT Asia HIV Observational Database. IAS 2013, Kuala Lumpur, Malaysia; 30 June ­ 03 July 2013
  26.  HBV and HCV co-infection: long term immunological, virological and survival outcomes following cART. IAS 2013, Kuala Lumpur, Malaysia; 30 June ­ 03 July 2013
  27. Trends in first-line antiretroviral therapy in Asia. ASHM 2013, Darwin, Australia, 21-23 October 2013 (oral presentation)
  28. The effects of frequency of CD4 monitoring on clinical endpoints in clinically stable HIV-infected patients with virologic suppression. IDWeek 2014, Philadelphia, USA, 8-12 Oct 2014
  29. Outcomes of tenofovir-based antiretroviral therapy in HBV/HIV co-infection: Results from the TREAT Asia HIV Observational Database. 16th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, Philadelphia, USA, 6-8 October 2014
  30. Outcomes of first-line antiretroviral therapy in HBV/HIV co-infection: Results from the TREAT Asia HIV Observational Database. Kirby’s internal Post Graduate Symposium 2014, 29 August 2014 (oral presentation)
  31. A Decade of Combination Antiretroviral Treatment in Asia: the TREAT Asia HIV Observational Database (TAHOD) cohort. AIDS 2014, Melbourne, Australia, 20-25 July 2014
  32. Hepatitis C virus RNA and genotype, IL28B genotype, and liver fibrosis scores in a regional cohort of HIV-infected HCV-exposed patients under routine HIV care in Asia. AIDS 2014, Melbourne, Australia, 20-25 July 2014
  33. Cancer Incidence in a Nationwide HIV/AIDS Patient Cohort in Taiwan in 1998-2009. CROI 2014, Boston, USA, 3-6 March 2014